VNRX VOLITIONRX LTD Management Changes 8-K Filing 2024 - Director Appointment VolitionRx Limited appointed Dr. Ethel Rubin as a new director effective September 30, 2024, with a quarterly compensation of $10,840 and a grant of 15,000 restricted stock units vesting over three years.Get access to all SEC 8-K filings of the VOLITIONRX LTD